Abstract
RESULTS
The proportion of LAP + CD4 + T cells was significantly higher in peripheral blood from patients (9.44% ± 3.18%) than healthy controls (1.49% ± 1.00%, P < 0.001). Among patients, the proportion of LAP + CD4 + T cells was significantly higher in tumor tissues (11.76% ± 3.74%) compared with paratumor tissues (3.87% ± 1.64%, P < 0.001). We also observed positive correlations between the proportion of LAP + CD4 + T cells and TNM stage (P < 0.001), distant metastasis (P < 0.001) and serum level of carcinoembryonic antigen (P < 0.05). Magnetic-activated cell sorting gave an overall enrichment of LAP + CD4 + T cells (95.02% ± 2.87%), which was similar for LAP -CD4 + T cells (94.75% ± 2.76%). In contrast to LAP -CD4 + T cells, LAP + CD4 + T cells showed lower Foxp3 expression but significantly higher levels of CTLA-4, CCR4 and CCR5 (P < 0.01). 
INTRODUCTION
Colorectal cancer (CRC) is the third most common carcinoma in men and second most common in women, with > 1 million new cases and > 500000 deaths every year worldwide [1, 2] . CRC progression is a complex process involving interactions between host cellular immunity factors and the tumor, which take place in the so-called tumor microenvironment [3, 4] . This environment includes numerous factors that promote tumor growth, such as energy and nutrients in blood vessels, growth factors from immune cells and stromal cells, and proinflammatory mediators secreted by tumor cells [5] . The environment also contains numerous factors that can limit tumor growth, such as tumor-infiltrating immune cells and tertiary lymphoid structures [6] . This complex mixture of factors largely determines patient prognosis and serves as an attractive therapeutic target [6, 7] . Several studies have suggested that during CRC progression, peripheral regulatory T (Treg) cells and myeloid suppressor cells increase in the tumor microenvironment, which is associated with worse prognosis [8] [9] [10] . Part of the reason appears to be that these cell populations counteract the host's antitumor immune response [11] . Downregulating Treg cells can render antitumor responses more effective, which may improve prognosis in patients with CRC and other malignant carcinomas [12] . LAP + CD4
+ T cells are a newly identified subset of Treg cells that express latent-associated peptide (LAP), and function within the latent transforming growth factor (TGF)-β complex to block interaction between TGF-β and receptors on immune cells [13] . [14] , and they are associated with autoimmune disease progression [13, [15] [16] [17] . 
MATERIALS AND METHODS

Ethics statement
All patients enrolled in this study provided written informed consent. The study protocol conformed to the ethical guidelines of the Declaration of Helsinki (Fortaleza, Brazil; October 2013), and it was approved by the Research Ethics Committee of the First Affiliated Hospital of Guangxi Medical University, China. resection margin (≥ 10 cm away from the tumor site) that was confirmed to be tumor-free based on routine pathology. The basic data regarding the study population are shown in Table 1 .
Study participants and samples
Patients were excluded if they (1) had already undergone CRC surgery or had been diagnosed with locoregional recurrence; or (2) were receiving any anticancer therapy, corticosteroids or other nonsteroidal anti-inflammatory drugs at the time of peripheral venous blood collection.
During the study period, peripheral blood was also collected from 25 healthy donors serving as a control group. Healthy controls were free of chronic pain, cardiovascular complaints, or other chronic inflammatory diseases. They were matched with patients in age and sex and showed no significant differences from patients.
Cell isolation
Peripheral blood mononuclear cells (PBMCs) were isolated from patients using Ficoll density gradient centrifugation. Fresh tumor and paratumor samples were washed three times in RPMI 1640; after which, fatty, connective and necrotic tissues were removed. Samples were cut into 1-2-mm cubes, transferred to a 50-mL beaker, and incubated for 3 h at room temperature with a triple-enzyme digestion medium containing 1 mg/mL collagenase IV, 30 μg/mL DNase Ⅰ and 0.1 mg/mL hyaluronidase (Sigma, St. Louis, MO, United States). Dissociated cell suspensions were filtered through a 70-μm nylon mesh, then tumorinfiltrating lymphocytes (TILs) were isolated from cell suspensions using discontinuous density gradient centrifugation [18] . LAP -
CD4
+ T cells and LAP + CD4 + T cells were isolated using a Magnetic cell sorting system (Miltenyi Biotec, Bergisch Gladbach, Germany). Cell purity was analyzed by flow cytometry as described below.
Flow cytometry
TILs and PBMCs were stimulated in culture for 4 h at 37 ℃ with 50 ng/mL phorbol-12-myristate-13-acetate, 1 μg/mL ionomycin, and 0.7 μL/mL GolgiStop reagent in a 5% CO2 incubator. T cells were identified based on surface or intracellular expression of markers labeled using antibodies ( 
Real-time quantitative polymerase chain reaction
Total RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA, United States), and firststrand cDNA was generated using oligo (dT) primers and the SuperScript Ⅲ First-Strand Synthesis System (Invitrogen) were determined using SYBR-based real-time polymerase chain reaction (7500 StepOnePlus system, Applied Biosystems, Carlsbad, CA, United States) and primers purchased from TaKaRa Biosystems (Table 2) . Relative expression levels were calculated using the 2 -ΔΔCT method and normalized to levels of β-actin mRNA.
Statistical analysis
Data were expressed as mean ± SD. Differences between two groups were assessed for significance using the Mann-Whitney U test, t-test, or paired t-test, as appropriate. All statistical tests were performed using SPSS version 16.0 (SPSS, Chicago, IL, United States), and the threshold of significance was defined as P < 0.05. + T cells in CRC Figure 2B ) and serum level of carcinoembryonic antigen (CEA) (P < 0.05; Figure 2C ) ( Figures 3 and 4) .
Magnetic-activated cell sorting in vitro
Magnetic-activated cell sorting gave an overall enrichment of LAP + CD4 + T cells (95.02% ± 2.87%; Figure 3A ) and enrichment was similar for LAP -CD4 + T cells (94.75% ± 2.76%; Figure 3B ).
Cytokine expression
The expression levels of cytokine profiles were measured by real-time qPCR, LAP + CD4 + T cells expressed significantly larger amounts of IL-10 and TGF-β but lower levels of IL-2, IL-4, IL-17 and IFN-γ, compared with LAP -CD4 + T cells (Table 4) .
DISCUSSION
Many carcinomas, including colorectal, gastric and nasopharyngeal cancer, are associated with elevated numbers of Treg cells [19] [20] [21] , and it is suggested that Treg cells promote tumor development and metastasis by inhibiting the proliferation of effector T lymphocytes [22] . LAP + CD4 + T cells, a recently identified subset of CD4 + Treg cells, have 50-fold more potent immunosuppressive activity than traditional CD4 + CD25 + T cells [13, 23] . Here we present several lines of evidence correlating LAP + CD4 + T cells with CRC progression. These cells were more abundant in peripheral blood and tumor tissue from patients with CRC compared with healthy controls. In CRC patients, the abundance of these cells correlated positively with TNM stage, metastasis, and serum level of CEA. CEA is the most widely used serum marker and is related to the prognosis of patients with CRC. The main use of CEA in CRC is in surveillance following curative resection for primary cancer [24, 25] . These In our study, expression of CCR4 and CCR5 was higher in LAP + CD4 + T cells than in LAP -CD4 + T cells. CCR4 and CCR5 are highly expressed in tumor microenvironments and appear to act as proinflammatory cytokine receptors [26, 27] . Some studies have reported that CCR4 and its ligands are associated with increased tumor recurrence and impaired overall survival in patients with gastric cancer [28, 29] . Wang et al [30] have shown that the CCL5/CCR5 axis blood from patients (9.44% ± 3.18%) than healthy controls (1.49% ± 1.00%, P < 0.001; Figure 1B and C). Among CRC patients, the proportion of LAP + CD4 + T cells was significantly higher in tumor tissue (11.76% ± 3.74%) compared with paratumor tissue (3.87% ± 1.64%, P < 0.001; Figure 1B and D).
RESULTS
LAP
Relationship between proportion of LAP + CD4 + T cells in tumor tissues and clinicopathological characteristics of CRC
We also observed positive correlations between the proportion of LAP + CD4
+ T cells and TNM stage (P < 0.001; Figure 2A ), distant metastasis (P < 0.001; [33] . CTLA-4 on CD4 + CD25 + Treg cells has been shown to suppress immune function through several mechanisms [34, 35] : increasing numbers of CD4 + CD25 + CTLA-4 T cells; inhibiting production of proinflammatory factors such as IFN-γ; increasing production of IL-2, IL-4, IL-10 and TGF-β1; and blocking tryptophan synthesis by antigen-presenting cells [36] . Under normal circumstances, these mechanisms can promote self-tolerance and prevent autoimmune disease and transplant rejection. Our results suggest that the CTLA-4 on LAP + CD4 + T cells help CRC tumors evade the host immune system, and one mechanism may be by inhibiting proliferation of effector T lymphocytes.
Our results reproduce most of those of Mahalingam et al [37] , using different procedures. We isolated LAP + CD4 + T cells and LAP -CD4 + T cells using a magnetic cell sorting system and analyzed cell purity by flow cytometry. Our results revealed that, after sorting, the purity of these two cells was > 90%. This is the first time that LAP + CD4 + T cells were isolated using a magnetic cell sorting system. In contrast to Mahalingam et al [37] , we found that LAP + CD4 + T cells expressed high levels of IL-10 and TGF-β. These cytokines play key roles in suppressing immune responses in mouse models of cerebral meningitis and allergic inflammation [13, 38, 39] . The immunoregulatory activity of Treg cells has been linked to several molecules, such as CTLA-4, TGF-β, and IL-10 [40, 41] . TGF-β has been shown to play an important role in the differentiation, maintenance and function of natural Treg cells [42] [43] [44] [45] . However, several studies have revealed the role of IL-10 in Treg cell suppression. It has been demonstrated that IL-10 is required for the homeostatic maintenance of the T cell number by Treg cells [46] and is involved in Treg-cell-mediated suppression in murine models of transplantation, graftversus-host disease, chronic parasite infection, colitis, and a rat model of type 1 diabetes [47] . 
Research frontiers
This is the first time that LAP + CD4 + T cells were isolated by using magnetic cell sorting system.
Innovations and breakthroughs
The authors found that LAP + CD4 + T cells accumulated in the tumor microenvironment of CRC patients and were involved in immune evasion mediated by interleukin-10 and TGF-β.
Applications
These findings suggest that investigating the functions and regulation of LAP + CD4 + T cells in CRC may improve our understanding of disease progression and treatment.
Terminology
LAP
+ CD4 + T cells are a newly identified subset of Treg cells that express LAP, and function within the latent TGF-β complex to block interaction between TGF-β and receptors on immune cells. CRC progression is a complex process involving interactions between host cellular immunity factors and the tumor, which take place in the so-called tumor microenvironment.
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